Main Topic Area
All Topic Areas
1 - 10 of 933 more >>
Articles
1 - 1 of 1
- Antagon Injection Consumer Information
Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely...
U.S. Food and Drug Administration
News
1 - 5 of 311 more >>
- Injection Drug Use Fueling Spread Of HIV In Mauritius
MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
- Vaginal lactate level predicts labor onset
Reuters - Wed, 10 Jan 2007 09:43 EST
- FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia
MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
- International Narcotics Control Board Hindering HIV/AIDS Control Efforts, Should Be Independently Reviewed, Report Says
MedicalNewsToday - Mon, 05 Mar 2007 12:00 EST
- More Frequent Participation In Needle-Exchange Programs Does Not Increase Risk Of HIV Infection, Study Says
MedicalNewsToday - Fri, 02 Mar 2007 06:00 EST
Clinical Trials
1 - 5 of 338 more >>
- Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats
ClinicalTrials.gov Identifier: NCT00529490 - Completed
Low Cardiac Output
- Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
ClinicalTrials.gov Identifier: NCT00340379 - Active, not recruiting
Affective Disorders
- Early Lactate- Directed Therapy on the ICU
ClinicalTrials.gov Identifier: NCT00270673 - Recruiting
Tissue Hypoxia; Hyperlactatemia
- Comparison of NIRS and Serum Lactate to Predict Poor Post-Operative Outcomes
ClinicalTrials.gov Identifier: NCT00485524 - Active, not recruiting
Congenital Disorders
- TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
Ovarian Neoplasms

Not Signed In -

